![](/img/cover-not-exists.png)
9021 Preliminary results of MAGE-A3 expression and baseline demographic data from MAGRIT, a large phase III trial of MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic) in adjuvant NSCLC
Zielinski, M., Laskowski, U., Bieselt, R., Reck, M., Strausz, J., Perdeus, J., Park, K., Atanackovic, D., Debois, M., Debruyne, C.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71734-3
Date:
September, 2009
File:
PDF, 66 KB
english, 2009